60 related articles for article (PubMed ID: 1446164)
1. Endogenous and exogenous factors modifying the activity of human liver cytochrome P-450 enzymes.
Wolff T; Strecker M
Exp Toxicol Pathol; 1992 Sep; 44(5):263-71. PubMed ID: 1446164
[TBL] [Abstract][Full Text] [Related]
2. Aldrin epoxidation, a highly sensitive indicator specific for cytochrome P-450-dependent mono-oxygenase activities.
Wolff T; Deml E; Wanders H
Drug Metab Dispos; 1979; 7(5):301-5. PubMed ID: 40770
[TBL] [Abstract][Full Text] [Related]
3. Rat liver cytochrome P-450 isozymes as catalysts of aldrin epoxidation in reconstituted monooxygenase systems and microsomes.
Wolff T; Guengerich FP
Biochem Pharmacol; 1987 Aug; 36(16):2581-8. PubMed ID: 3606656
[TBL] [Abstract][Full Text] [Related]
4. Relationship between oxidative metabolism of 2-acetylaminofluorene, debrisoquine, bufuralol, and aldrin in human liver microsomes.
McManus ME; Boobis AR; Minchin RF; Schwartz DM; Murray S; Davies DS; Thorgeirsson SS
Cancer Res; 1984 Dec; 44(12 Pt 1):5692-7. PubMed ID: 6498831
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the cytochrome P450 isozyme that metabolizes ochratoxin A, using metabolic inducers, inhibitors and antibodies.
Hietanen E; Bartsch H; Béréziat JC; Castegnaro M; Michelon J
IARC Sci Publ; 1991; (115):297-304. PubMed ID: 1820345
[TBL] [Abstract][Full Text] [Related]
6. Individuality in cytochrome P450 expression and its association with the nephrotoxic and carcinogenic effects of chemicals.
Wolf CR
IARC Sci Publ; 1991; (115):281-7. PubMed ID: 1820342
[TBL] [Abstract][Full Text] [Related]
7. Differences in the biochemical properties of aldrin epoxidase, a cytochrome P-450-dependent monooxygenase, in various tissues.
Van Cantfort J; Léonard-Poma M; Sèle-Doyen J; Gielen JE
Biochem Pharmacol; 1983 Sep; 32(18):2697-702. PubMed ID: 6626240
[TBL] [Abstract][Full Text] [Related]
8. Induction of hepatic cytochrome P-450 by phenobarbital in semi-aquatic frog (Rana pipiens).
Khan MA; Qadri SY; Tomar S; Fish D; Gururajan L; Poria MS
Biochem Biophys Res Commun; 1998 Mar; 244(3):737-44. PubMed ID: 9535735
[TBL] [Abstract][Full Text] [Related]
9. Difference between species in response to a 3,5-dichloropyridyloxyphenoxy compound: induction of cytochrome P-450 and/or peroxisome proliferation.
Schmidt U; Machemer L
Food Addit Contam; 1989; 6 Suppl 1():S41-55. PubMed ID: 2599155
[TBL] [Abstract][Full Text] [Related]
10. The role of cytochrome P4503A1/2 in the sex-specific sulfoxidation of the hexachlorobutadiene metabolite, N-acetyl-S-(pentachlorobutadienyl)-L-cysteine in rats.
Werner M; Birner G; Dekant W
Drug Metab Dispos; 1995 Aug; 23(8):861-8. PubMed ID: 7493554
[TBL] [Abstract][Full Text] [Related]
11. Ontogeny of monooxygenase activities in the marmoset monkey (Callithrix jacchus).
Schulz-Schalge T; Heger W; Webb J; Kastner M; Neubert D
J Med Primatol; 1991 Sep; 20(7):325-33. PubMed ID: 1787526
[TBL] [Abstract][Full Text] [Related]
12. Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes.
Beaune PH; Kremers PG; Kaminsky LS; De Graeve J; Albert A; Guengerich FP
Drug Metab Dispos; 1986; 14(4):437-42. PubMed ID: 2873991
[TBL] [Abstract][Full Text] [Related]
13. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
[TBL] [Abstract][Full Text] [Related]
14. Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes.
Campbell ME; Grant DM; Inaba T; Kalow W
Drug Metab Dispos; 1987; 15(2):237-49. PubMed ID: 2882985
[TBL] [Abstract][Full Text] [Related]
15. Monooxygenase-catalyzed aldrin epoxidation and dihydroisodrin hydroxylation in monkey liver needle-biopsy specimens. Assay and properties.
Krieger RI; Gee SJ; Miller JL; Thongsinthusak
Drug Metab Dispos; 1976; 4(1):28-34. PubMed ID: 3398
[TBL] [Abstract][Full Text] [Related]
16. Induction of monooxygenase and UDP-glucuronosyltransferase activities in primary cultures of rat hepatocytes.
Forster U; Luippold G; Schwarz LR
Drug Metab Dispos; 1986; 14(3):353-60. PubMed ID: 2872038
[TBL] [Abstract][Full Text] [Related]
17. N,N',N''-triethylenethiophosphoramide (thio-TEPA) oxygenation by constitutive hepatic P450 enzymes and modulation of drug metabolism and clearance in vivo by P450-inducing agents.
Ng SF; Waxman DJ
Cancer Res; 1991 May; 51(9):2340-5. PubMed ID: 1707751
[TBL] [Abstract][Full Text] [Related]
18. Oxidative metabolism of zolpidem by human liver cytochrome P450S.
Pichard L; Gillet G; Bonfils C; Domergue J; Thénot JP; Maurel P
Drug Metab Dispos; 1995 Nov; 23(11):1253-62. PubMed ID: 8591727
[TBL] [Abstract][Full Text] [Related]
19. Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem.
Pichard L; Gillet G; Fabre I; Dalet-Beluche I; Bonfils C; Thenot JP; Maurel P
Drug Metab Dispos; 1990; 18(5):711-9. PubMed ID: 1981725
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a PCN-P450 enzyme in chickens and comparison of its development with that of other phenobarbital-inducible forms.
Lorr NA; Bloom SE; Park SS; Gelboin HV; Miller H; Friedman FK
Mol Pharmacol; 1989 May; 35(5):610-6. PubMed ID: 2725470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
